Skip to content
AI IntelligenceNov 12, 2026Primary Market
Article

Biomatter · $18M · Series A

Biomatter, a company specializing in custom enzyme design, raised $18M in an oversubscribed Series A funding round led by Astanor, with participation from existing investors UVC Partners and others.

AI-generated: summaries written by AI from the linked sources. How we use AI

AI-generatedSource: tech.eu
01

Source Brief

Biomatter, a company specializing in custom enzyme design, raised $18M in an oversubscribed Series A funding round led by Astanor, with participation from existing investors UVC Partners and others.